Benzinga | Nov 11, 2021 04:13PM EST

BioLife Solutions Q3 EPS $(0.19) Misses $(0.09) Estimate, Adj. EBITDA Loss $2.1M, Sales $33.80M Beat $31.61M Estimate

BioLife Solutions (NASDAQ:BLFS) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.09) by 111.11 percent. This is a 850 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $33.80 million which beat the analyst consensus estimate of $31.61 million by 6.93 percent. This is a 199.67 percent increase over sales of $11.28 million the same period last year.